Search Constraints
« Previous |
41 - 60 of 209
|
Next »
Search Results
Select an image to start the slideshow
On the Brauer group of a local field
1 of 20
Characterizing the role of recurrent histone H3 mutations in cancer initiation
2 of 20
Pharmacological analysis of liver-directed AAV-fVIII gene therapy and anti-fVIII inhibitor incidence in a preclinical model of hemophilia A
3 of 20
The impact of diabetes and pre-diabetes on prevalence of Mycobacterium tuberculosis infection among household contacts of active tuberculosis cases in Ethiopia
4 of 20
Metabolomic Analysis of Microbial Small Molecules in Non-Alcoholic Fatty Liver Disease
5 of 20
Time of trauma prospectively affects PTSD symptom severity: the impact of circadian rhythms and cortisol
6 of 20
LCMT-1 is a negative regulator of inflammation and cancer-related signaling pathways
7 of 20
Real World Outcomes of Melanoma Brain Metastases Treated with Immunotherapy with or without Stereotactic Radiosurgery
8 of 20
Enhancing HIV Pre-Exposure Prophylaxis Training in Publicly Funded Family Planning Clinics in the Southern United States using an Implementation Science Framework
9 of 20
Temporal Changes of Protein Biomarkers in Sepsis-Induced Acute Respiratory Distress Syndrome
10 of 20
Glyoxal-based Caging of Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Viral Infections
11 of 20
SWEAT ICU – Study of Workload and the Association of Outcomes in the Intensive Care Unit
12 of 20
A dose-escalation clinical trial of intranasal ketamine for uncontrolled cancer-related pain
13 of 20
Comparison of two models of GRN-deficiency using quantitative proteomics
14 of 20
Galectin-9 Expression and its Role in Biliary Tract Cancers
15 of 20
Shared Decision-Making for Implantable Cardioverter-Defibrillators: Past, Present, and Future
16 of 20
Evaluation of Emerging Biomarkers to Identify Aspirin-Exacerbated Respiratory Disease
17 of 20
Dynamic in vitro and in vivo protein methylation mapping using a chemoenzymatic approach
18 of 20
The Impact of Churn on HIV Outcomes in a Southern United States Clinical Cohort
19 of 20
Central nervous system prophylaxis in aggressive B-cell non-Hodgkin lymphomas
20 of 20